We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Vita Life Sciences Limited is a drug manufacturers-specialty & generic business based in Australia. Vita Life Sciences shares (VLS) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Vita Life Sciences has a trailing 12-month revenue of around $50.2 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.8167 - $2 |
|---|---|
| 50-day moving average | $1.6545 |
| 200-day moving average | $1.2408 |
| Target price | $0.85 |
| PE ratio | 13.2813 |
| Dividend yield | $0.055 (3.24%) |
| Earnings per share (TTM) | $0.128 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.7
| 1 week (2021-11-22) | 1.7 |
|---|---|
| 1 month (2021-10-29) | -10.05% |
| 3 months (2021-08-27) | 37.10% |
| 6 months (2021-05-28) | 45.30% |
| 1 year (2020-11-27) | 93.18% |
|---|---|
| 2 years (2019-11-29) | 176.42% |
| 3 years (2018-11-29) | 78.01% |
| 5 years (2016-11-29) | 28.79% |
Valuing Vita Life Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Vita Life Sciences 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Vita Life Sciences 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Vita Life Sciences shares trade at around 13x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Vita Life Sciences 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.6 million (£0.0 million).
The EBITDA is a measure of a Vita Life Sciences 's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $50.2 million |
|---|---|
| Operating margin TTM | 16.87% |
| Gross profit TTM | $29.3 million |
| Return on assets TTM | 13.5% |
| Return on equity TTM | 25.55% |
| Profit margin | 13.38% |
| Book value | 0.491 |
| Market capitalisation | $89.5 million |
TTM: trailing 12 months
Dividend payout ratio: 42.31% of net profits
Recently Vita Life Sciences has paid out, on average, around 42.31% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Vita Life Sciences shareholders could enjoy a 3.24% return on their shares, in the form of dividend payments. In Vita Life Sciences 's case, that would currently equate to about A$0.055 per share.
While Vita Life Sciences 's payout ratio might seem fairly standard, it's worth remembering that Vita Life Sciences may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 23 September 2021 (the "ex-dividend date").
Vita Life Sciences 's shares were split on 1 July 2009.
Over the last 12 months, Vita Life Sciences 's shares have ranged in value from as little as $0.8167 up to $2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Vita Life Sciences 's is 0.1797. This would suggest that Vita Life Sciences 's shares are less volatile than average (for this exchange).
Vita Life Sciences Limited, a pharmaceutical and healthcare company, engages in formulation, packaging, distribution, and sale of vitamins and supplements. It offers a range of supplements, vitamins, minerals, herbs, and superfoods. The company markets its products through pharmacies and health food stores under the Herbs of Gold, VitaHealth, VitaScience, and VitaLife brands. It operates in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, China, and internationally. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.
Get up to 58% off on robot cleaners to barrels and cordless sticks to all things Dyson during the Black Friday sales.
These are the best Black Friday deals for Nintendo Switch, including up to 59% off bestselling Switch games.
The best Black Friday 2021 discounts include over $1,000 off 75-inch and 85-inch smart TVs from Samsung and Hisense.
Black Friday bargains include discounts on the Apple Watch Series 3 and Apple Watch accessories.
Save up to 84% off select air fryers and multi cookers on Black Friday from Amazon, eBay and Catch and more.
Get the Nintendo Switch bundled with Mario Kart 8 Deluxe and a 3-month Nintendo Switch Online subscription for $369 - save $160!
The biggest discounts include $200 off the Apple AirPods Max, 40% off the Beats Solo3, 38% off Jabra Elite 75t Earbuds and 56% off Sennheiser HD 400s.
Save over $1000 on gaming laptops during Black Friday 2021 from Dell, MSI, Lenovo, OMEN and Alienware and more.
